Printer Friendly

CALGENE APPOINTS VICE PRESIDENT FOR RESEARCH

           CALGENE APPOINTS VICE PRESIDENT FOR RESEARCH
    DAVIS, Calif., Nov. 8 /PRNewswire/ -- Calgene Inc. (NASDAQ: CGNE)


announced today that Dr. Vic Knauf has been promoted to vice president for Research. He was previously the Oilseeds Division research director.
    Knauf joined Calgene in February 1983 after receiving his doctorate in microbiology and immunology at the University of Washington.  He has had primary responsibilities over the last seven years for managing the plant oil modification research program, the largest research effort at Calgene.  Under Knauf's leadership, Calgene scientists have established a clear technical lead in plant oil modification.  Calgene was the first to express a gene specifically in seeds of a major oilseed crop, the first to clone a commercially important plant gene involved in oil synthesis and the first to modify oil composition in rapeseed, a major oilseed crop.
    Roger Salquist, Calgene's chief executive officer, said, "Dr. Knauf has demonstrated uncommon tenacity and commitment in leading the Calgene oils research team to the string of breakthroughs and successes.  He has the ability to build consensus and to make tough and timely decisions.  The Calgene research and development organization has accomplished more than any of our competitors in this field in the past five years and this promotion is recognition of that fact."
    Don Helinski, Ph.D., chairman of Calgene's Science Advisory Council and director of the Center for Molecular Genetics at the University of California, San Diego, said, "Dr. Knauf has clearly established himself as a scientific leader who not only has made outstanding scientific contributions to Calgene's oil modification program but he has shown the vision and scientific managerial skills that are necessary to sustain Calgene's leadership in plant biotechnology.  The appointment of Vic as vice president for research has the full and enthusiastic support of Calgene's scientific advisors."
   Calgene has invested over $80 million in research and development since its inception in 1980.  Currently, Calgene employs 120 research and support staff and has research and development expenditures of approximately $13 million annually.  The company focuses its research on three core crops -- tomato, cotton and rapeseed.  In 1991 the company was the first to file with the FDA a genetically engineered food, its FLAVR SAVR(TM) tomato.  It recently completed the largest engineered field trial ever with its 34 location Bromotol(TM) safened cotton conducted in 12 states.  In October Calgene received approval from the USDA to conduct the world's first field tests of canola genetically engineered to produce a modified vegetable oil.
    Calgene is an agribusiness biotechnology company that is developing improved plant varieties and plant products for the seed, food and specialty chemical industries.  The company has three operating subsidiaries -- Ameri-Can Pedigreed Seed Co., Calgene Chemical and Stoneville Pedigreed Seed Co.
    -0-                  11/8/91
    /CONTACT:  Daniel Wagster of Calgene Inc. 916-753-6313/
    (CGNE) CO:  Calgene Inc. ST:  Californis IN:  FOD SU:  PER DB -- SF001 -- 2462 11/08/91 08:01 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 8, 1991
Words:482
Previous Article:TAB DECLARES CASH DIVIDEND
Next Article:SKYWEST INC. REPORTS SECOND QUARTER RESULTS
Topics:


Related Articles
CALGENE ANNOUNCES FIRST QUARTER RESULTS
CALGENE FORMS FRESH PRODUCE COMPANY: THOMAS CHURCHWELL APPOINTED CHIEF EXECUTIVE OFFICER
CALGENE FRESH APPOINTS VICE PRESIDENT, RESEARCH AND DEVELOPMENT
CALGENE APPOINTS MOTRONI TO VICE PRESIDENT OF FINANCE; WAGSTER TO HEAD OPERATIONS AT CALGENE FRESH
CALGENE NAMES RODERICK STACEY AS PRESIDENT AND CHIEF OPERATING OFFICER; COMPANY NAMES HEADS OF OILS AMD COTTON DIVISIONS
CALGENE ANNOUNCES FIVE PROMOTIONS; TWO NEW OFFICERS NAMED
CALGENE RECEIVES PLANT OILS SYNTHASE AND THIOESTERASE GENE PATENTS
CALGENE GRANTED ADDITIONAL SEED-SPECIFIC CANOLA PROMOTER PATENT
CALGENE ANNOUNCES PLANNED $50 MILLION EQUITY INVESTMENT BY MONSANTO
Stoneville Confirms 1996 Official Yield Trial Results

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters